DOJ, Drugmakers Spar After Justices Snub 6 Negotiation Suits
The U.S. Department of Justice is trying to have it both ways in drug pricing litigation, telling the U.S. Supreme Court not to intervene before additional circuits decide pending challenges and...To view the full article, register now.
Already a subscriber? Click here to view full article